06/03/2025/
Executive Summary For decades, the pharmaceutical industry has faced the same recurring problems with clinical development: the struggle to fully...
Volv Global provides data-driven understanding of disease endpoints and outcomes to support pricing and reimbursement calculations, regulatory and HTA submissions, payer evidence packages and comparative economics studies with real-world evidence.
Analyse real-world treatment pathways and their effectiveness to define more precise endpoints for better analysis of disease progression, outcomes.
Compare treatment effectiveness via analysis of real-world outcomes of different intervention.
Identify cohorts more precisely and at an early stage for better longitudinal assessment of patient health outcomes.
Understand the real-world impact on quality of life and healthcare utilization for payer evidence packages and comparative economic studies
Value, access and HEOR in the face of complexity
Integrating real-world evidence (RWE) to understand the real-world clinical, economic, and social impact of disease on quality of life and healthcare utilisation.
Disparate healthcare systems and patient populations create inconsistent datasets lacking standardised outcome measures.
Linking medical records to cost-related data is often difficult.
Differences in healthcare access across regions affect generalisability of findings.
Supporting Clinical Development
We find undiagnosed and misdiagnosed patients, expanding the pool of patients for clinical trial recruitment.
We find patients before the development of traditional symptoms, before they are given conventional therapies.
We enable triage of patients according to prognosis of outcomes, e.g., fast progressors, or progressors to more acute symptoms.
We differentiate and cluster heterogeneous patient cohorts for more accurate definition of trial inclusion and exclusion criteria.
Leading AI/ML methodology to support Value and Access, HEOR
Through comprehensive data integration from clinical and claims sources, inTrigue equips Value & Access and HEOR teams to quantify the real-world performance of therapies. By merging clinical, claims, and other healthcare data, inTrigue provides a holistic view of disease burden, allowing for robust cost-effectiveness and outcomes analyses. This data-backed insight aids stakeholders in demonstrating value to payers, supporting earlier detection strategies, and ultimately enhancing patient access through clearer evidence of a therapy’s impact.
Success stories with clinical development
Our technology has already made a significant difference in the lives of many patients.
Here are a few examples of how Volv Global and inTrigue have enabled earlier detection and transformed patient care:
Shaping the future today
Executive Summary For decades, the pharmaceutical industry has faced the same recurring problems with clinical development: the struggle to fully...
Alpha-1 antitrypsin deficiency (AATD), a rare genetic condition, can cause lung disease in adults with symptoms similar to chronic obstructive...
Shaping the future today
Ready to shape the future of healthcare? Let’s explore how our machine learning solutions can accelerate diagnoses, refine patient journeys, and drive meaningful impact for those who need it most. We value your ideas and expertise, reach out now to unlock new possibilities together.